Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IRBESARTAN Cause Wrong technique in product usage process? 65 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Wrong technique in product usage process have been filed in association with IRBESARTAN (Irbesartan). This represents 0.6% of all adverse event reports for IRBESARTAN.

65
Reports of Wrong technique in product usage process with IRBESARTAN
0.6%
of all IRBESARTAN reports
0
Deaths
7
Hospitalizations

How Dangerous Is Wrong technique in product usage process From IRBESARTAN?

Of the 65 reports, 7 (10.8%) required hospitalization, and 4 (6.2%) were considered life-threatening.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 65 reports have been filed with the FAERS database.

What Other Side Effects Does IRBESARTAN Cause?

Acute kidney injury (1,361) Fall (795) Hypotension (686) Nausea (533) Drug ineffective (532) Malaise (488) Hyponatraemia (485) Fatigue (483) Blood pressure increased (477) Hyperkalaemia (454)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which IRBESARTAN Alternatives Have Lower Wrong technique in product usage process Risk?

IRBESARTAN vs IRINOTECAN IRBESARTAN vs IRON IRBESARTAN vs IRON DEXTRAN IRBESARTAN vs IRON ISOMALTOSIDE 1000 IRBESARTAN vs IRON POLYMALTOSE

Related Pages

IRBESARTAN Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process IRBESARTAN Demographics